List View Detail View 1826-1850 of 34746 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 73 74 75 ... 1390 Next Product Clone Appl. Reg Cat# Size Price Quantity See more size options for this product on the previous page. PerCP/Cyanine5.5 anti-mouse CD43 Activation-Associated Glycoform Antibody 1B11 FC RUO 121224 100 µg 358 CHF Purified anti-mouse CD43 Activation-Associated Glycoform Antibody 1B11 FC, IHC-F, IP, WB RUO 121202 200 µg 206 CHF TotalSeq™-B1284 anti-MU CD43 Activation-Associated Glycoform Antibody 1B11 PG RUO 121227 10 µg 369 CHF TotalSeq™-C1284 anti-MU CD43 Activation-Associated Glycoform Antibody 1B11 PG RUO 121229 10 µg 369 CHF FITC anti-mouse TCR vβ8.3 Antibody 1B3.3 FC RUO 156305 25 µg 118 CHF 156306 100 µg 253 CHF PE anti-mouse TCR vβ8.3 Antibody 1B3.3 FC RUO 156303 25 µg 129 CHF 156304 100 µg 223 CHF Purified anti-mouse TCR vβ8.3 Antibody 1B3.3 FC RUO 156302 500 µg 229 CHF TotalSeq™-A1139 anti-mouse TCR vβ8.3 Antibody 1B3.3 PG RUO 156307 10 µg 369 CHF PE anti-human TSLPR (TSLP-R) Antibody 1B4 FC RUO 322805 25 tests 141 CHF 322806 100 tests 304 CHF APC anti-human TSLPR (TSLP-R) Antibody 1B4 FC RUO 322807 25 tests 154 CHF 322808 100 tests 332 CHF APC/Fire™ 750 anti-human TSLPR (TSLP-R) Antibody 1B4 FC RUO 322813 25 tests 159 CHF 322814 100 tests 370 CHF Purified anti-human TSLPR (TSLP-R) Antibody 1B4 FC, WB RUO 322802 100 µg 218 CHF Biotin anti-human TSLPR (TSLP-R) Antibody 1B4 FC RUO 322804 100 µg 241 CHF PE/Cyanine7 anti-human TSLPR (TSLP-R) Antibody 1B4 FC RUO 322810 100 tests 382 CHF PerCP/Cyanine5.5 anti-human TSLPR (TSLP-R) Antibody 1B4 FC RUO 322812 100 tests 382 CHF APC anti-human CD18 Antibody 1B4/CD18 FC RUO 373405 25 tests 125 CHF 373406 100 tests 303 CHF Alexa Fluor® 488 anti-human CD18 Antibody 1B4/CD18 FC RUO 373403 25 tests 147 CHF 373404 100 tests 323 CHF PE anti-human CD18 Antibody 1B4/CD18 FC RUO 373407 25 tests 110 CHF See more size options for this product on the next page. Results Per Page: 25 50 100 200 Previous 1 ... 73 74 75 ... 1390 Next
Follow Us